Header Logo

Connection

Danny Dhanasekaran to Ovarian Neoplasms

Back to Details
This is a "connection" page, showing publications Danny Dhanasekaran has written about Ovarian Neoplasms.
Danny Dhanasekaran
Connection Strength
5.042
Ovarian Neoplasms
  1. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
    View in: PubMed
    Score: 0.593
  2. GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 2021 08 14; 11(8).
    View in: PubMed
    Score: 0.492
  3. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
    View in: PubMed
    Score: 0.408
  4. LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res. 2018 04 15; 78(8):1923-1934.
    View in: PubMed
    Score: 0.385
  5. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer. Oncotarget. 2016 Nov 08; 7(45):72845-72859.
    View in: PubMed
    Score: 0.354
  6. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gai2, Src, and HIF1a signaling nexus. Oncotarget. 2016 Jun 21; 7(25):37664-37679.
    View in: PubMed
    Score: 0.344
  7. LPA-mediated migration of ovarian cancer cells involves translocalization of Gai2 to invadopodia and association with Src and ß-pix. Cancer Lett. 2015 Jan 28; 356(2 Pt B):382-91.
    View in: PubMed
    Score: 0.306
  8. The gep proto-oncogene Ga12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. Cell Signal. 2014 Jan; 26(1):122-32.
    View in: PubMed
    Score: 0.285
  9. NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024 Nov 04; 13(21).
    View in: PubMed
    Score: 0.154
  10. Tailored chemotherapy: Innovative deep-learning model customizing chemotherapy for high-grade serous ovarian carcinoma. Clin Transl Med. 2024 Sep; 14(9):e1774.
    View in: PubMed
    Score: 0.152
  11. Ovarian Cancer Cell-Conditioning Medium Induces Cancer-Associated Fibroblast Phenoconversion through Glucose-Dependent Inhibition of Autophagy. Int J Mol Sci. 2024 May 23; 25(11).
    View in: PubMed
    Score: 0.149
  12. Optical Coherence Tomography of Tumor Spheroids Identifies Candidates for Drug Repurposing in Ovarian Cancer. IEEE Trans Biomed Eng. 2023 06; 70(6):1891-1901.
    View in: PubMed
    Score: 0.139
  13. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Cancer Lett. 2022 08 28; 542:215735.
    View in: PubMed
    Score: 0.130
  14. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 2021 11 17; 10(11).
    View in: PubMed
    Score: 0.125
  15. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer. Mol Carcinog. 2021 05; 60(5):297-312.
    View in: PubMed
    Score: 0.120
  16. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. 2019 11; 38(45):7089-7105.
    View in: PubMed
    Score: 0.107
  17. Cystathionine ß-synthase regulates mitochondrial morphogenesis in ovarian cancer. FASEB J. 2018 08; 32(8):4145-4157.
    View in: PubMed
    Score: 0.097
  18. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
    View in: PubMed
    Score: 0.092
  19. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. 2016 Dec 13; 7(50):83148-83159.
    View in: PubMed
    Score: 0.089
  20. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Cancer Res Treat. 2017 Apr; 49(2):338-349.
    View in: PubMed
    Score: 0.087
  21. Metformin induces degradation of cyclin D1 via AMPK/GSK3? axis in ovarian cancer. Mol Carcinog. 2017 02; 56(2):349-358.
    View in: PubMed
    Score: 0.085
  22. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells. Cancer Lett. 2016 Feb 28; 371(2):347-53.
    View in: PubMed
    Score: 0.083
  23. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016 Feb 01; 371(1):30-7.
    View in: PubMed
    Score: 0.083
  24. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015 Nov 10; 6(35):37367-84.
    View in: PubMed
    Score: 0.083
  25. Ovarian cancer. Biomed Res Int. 2014; 2014:764323.
    View in: PubMed
    Score: 0.078
  26. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. Mol Carcinog. 2017 Dec; 56(12):2681-2691.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.